Table 4. Accelerated stability test of PESE (n=3) .
| Formulation | Month | Transmittance (%) | Globule size (nm) | PDI |
| F5 | 1 | 98.39±0.10 | 15.8±0.1 | 0.11±0.08 |
| 2 | 97.98±0.02 | 20.6±0.4 | 0.29±0.07 | |
| 3 | 97.28±0.01 | 12.4±0,1 | 0.27±0.06 | |
| F6 | 1 | 98.53±0.06 | 17.3±0.1 | 0.15±0.08 |
| 2 | 97.50±0.08 | 18.1±0.1 | 0.21±0.08 | |
| 3 | 97.01±0.02 | 15.9±0.2 | 0.17±0.04 | |
| F7 | 1 | 97.81±0.10 | 18.7±0.1 | 0.29±0.09 |
| 2 | 97.80±0.01 | 19.0±0.2 | 0.25±0.02 | |
| 3 | 97.52±0.02 | 18.9±0.2 | 0.16±0.06 | |
| F8 | 1 | 98.26±0.25 | 37.9±0.2 | 0.28±0.07 |
| 2 | 96.57±0.02 | 32.1±0.8 | 0.14±0.07 | |
| 3 | 94.45±0.01 | 32.2±0.2 | 0.24±0.02 |
The variations of the averages are shown as SD.